Macrophage migration inhibitory factor: a potential biomarker for chronic low back pain in patients with Modic changes

Methods Analyses were based on incident cases of LADA (n = 425) and type 2 diabetes (n = 1420), and 1704 randomly selected control participants from a Swedish case–control study

Methods: Participants with mild traumatic brain injury (MTBI; n = 140), orthopedic trauma (n = 72), and healthy community controls (n = 70) from the Trondheim MTBI follow-up

Methods: Head steadiness in terms of head motion velocity was compared in subjects with whiplash (n = 59), non-trau- matic neck pain (n = 57) and healthy controls (n = 57)

Figure 1 Proportion with cardiovascular disease, cancer, type 2 diabetes and chronic obstructive pulmonary disease in the age group 40 years or older in the total population (N = 2

This study compared patients with polysubstance use disorder who remained abstinent, patients who relapsed, and healthy controls on changes in self-reported ADHD symptoms from

Cost–utility analysis of antibiotic treatment in patients with chronic low back pain and Modic changes: results from a randomised, placebo- controlled trial in Norway (the

The candidate molecules 1 and 5 did not show any detectable inhibitory activity when tested in the presence of healthy controls or RA-patients serum, nor in patients synovial

Methods: Cytokines were measured in CSF and serum by multiplex assay in adult patients with encephalitis of infectious, autoimmune or unknown etiology ( n = 10), aseptic